Skip to main content
. 2022 Dec 17;4:100148. doi: 10.1016/j.crphar.2022.100148

Fig. 5.

Fig. 5

Inhibition of endogenous cytoplasmic ROS in SNB-19 and LN-229 ​cells by TPP-conjugated peptides (2-h treatment) according to flow cytofluorometry with DCFDA probe. (A) Relative cell number (total amount ​= ​100%) in cell populations 1 and 2. (B) Fluorescence distributions in control cells (filled curve) and cells treated with 0.2 ​mM TPP3-YrFK (unfilled curve). Mean ​± ​SEM (n ​= ​3, ∗p ​< ​0.05, ∗∗p ​< ​0.01, ∗∗∗p ​< ​0.001 vs. Ctrl).